Unlike other established scientific manifestations, SUUMC Days National Conference bring together, first of all, colleagues from the structures of the Ministry of National Defense, as well those from similar institutions, within the national security system.

Synttergy Consult participated at the event with the symposium titled “Troponine - Our everyday dilemma". The topics discussed were:

• Does the patient have POSITIVE troponin? Is hospitalized in cardiology!
• Does the patient have POSITIVE troponin? Is not hospitalized in cardiology!

Lecturers:

• Medical colonel university assistant Dr. Alice Munteanu – Primary physician Cardiology - University Hospital of Central Military Emergency "Dr. Carol Davila"
• Lieutenant Colonel Doctor Dr. Silviu Ionel Dumitrescu – Chief Medical Doctor Cardiology - University Hospital of Central Military Emergency "Dr. Carol Davila"

This year celebrated the 45th anniversary of the SRATI Society and implicitly a 45-year history of the SRATI Congress, a period in which the specialty of anesthesia and intensive care has grown enormously and in which the history of SRATI Society overlaps the history of Romanian medicine.

Synttergy Consult participated at the event with the symposium titled "Buy time for life in severe infections". The topics debated have been:

• Buy time for life in severe infections
• A call to action for antimicrobial stewardship in the emergency department
• Multirezistenta bacteriana in sectii de terapie intensiva; necesitatea metodelor rapide de diagnostic

Lecturers:

• Prof. Dr. Diana Cimpoesu - Chief Medical Doctor UPU-SMURD Iasi - Emergency Clinical Hospital "Sf. Spiridon" Iasi
• Prof. Dr. Dorel Sandesc – Chief Medical Doctor ATI - Emergency Clinical Hospital "Pius Branzeu" Timisoara
• Prof. Dr. Monica Licker - Chief Medical Doctor Bacteriology unit - Emergency Clinical Hospital "Pius Branzeu" Timisoara

Pneumonia and sepsis are probably the two most important infections that require the shortest possible time to get a result (TTR). The use of standard microbiological techniques based primarily on methods that require the cultivation of germs on culture media, offers a result after 24/36 h from harvesting the biological product. Introducing alternative techniques, based primarily on DNA amplification tests, has recently changed the diagnosis approach for a large group of severe infections. Moreover, the use of DNA amplification tests has made it possible to insert the so-called "syndromic approach" into the microbiological workflow. The syndromic approach is based on the ability to detect more than one germ among a group of potential pathogens. This new technique has changed the perspective of addressing diagnostic tests from "trying to identify the responsible germ" in "tell me which germs are potentially responsible for the infection." This diagnostic approach has also proven to be effective in terms of speed, because the time to get the result is reduced to less than 6 hours. The presentation below describes the most recent multiplex PCR application for the diagnosis of severe infections and provides an understanding of the clinical meaning and usefulness of the results.

See here how it works

Description Unyvero Panel

Presepsin is a reliable, sensitive and specific sepsis marker, whose serum levels will be highlighted earlier than other biomarkers. More, the Presepsin level is an important tool in the diagnosis of sepsis and allows stratification of the severity of septic patients. Presepsin's concentration correlates with the  APACHE II, GCS, MEDS and SOFA scores, and the prevalence of organ dysfunction. Therefore, Presepsin is an early predictor of host response and mortality in septic patients.

Presepsin can be used to diagnose sepsis in various clinical situations or to monitor the effectiveness of antibiotic therapy.

Apart from diagnostic utility, Presepsin appears to be a strong predictor for complications and outcome in patients undergoing surgery.

Learn more about the unique Point-of-Care equipment that can determine Sepsis Marker Presepsin here.

The conference, already at the 10th edition, intends to open a new decade by switching to a new format, with different activities and renowned lecturers, but respecting the same principle: the conference is a forum that allows the exchange of ideas and experiences among all rescuers.

Synttergy Consult participated at the event with the symposium titled "Critical Patient: The Synergy of Rapid Methods in the Emergency Department". The topics debated have been:

• News in European Emergency Medicine Guides
• Presepsin - biomarker of the inflammatory response
• Algorithm 0/1 h in NSTEMI. How can it help in current practice
• Benefits of rapid syndrome testing for critical patients

Lecturers:

• Prof. Dr. Diana Cimpoesu - Chief Medical Doctor UPU-SMURD Iasi - Emergency Clinical Hospital "Sf. Spiridon" Iasi
• Conf. Dr. Luciana Rotaru - Head of Emergency Unit UPU-SMURD Craiova - Emergency County Clinic Hospital Craiova
• Conf. Dr. Adela Golea - Medical Director - Cluj-Napoca County Emergency Clinical Hospital
• Dr. Yoann Personne - Director of the Scientific Department, Curetis GmbH

The use of troponin as a "gold standard" biochemical marker has rapidly led to an increase in the number of patients for whom the potential myocardial infarction diagnostic is not real, although they exhibit an elevated level of troponin. Chronic elevated levels of troponin have been observed in patients with renal impairment. Recommendations to use a threshold value for the 99th percentile together with the improved test sensitivity have led to an increase in pathologies associated with elevated levels of troponin.

The European Cardiology Guide recommends testing patients with high-sensitivity troponin at intake and after three hours or, at intake and after one hour if there are validation studies of the algorithm 0/1 h.

Repeated testing allows immediate discrimination between acute and chronic myocardial injury. This solves the dilemma of patients with chronic kidney disease or other cardiac pathologies, associated with elevated levels of troponin. An elevated level of troponin is expected in patients with renal insufficiency. A change in troponin concentration indicates an acute injury and may be associated with a myocardial infarction. Instead, an increased level of troponin that does not vary over time indicates a chronic condition and requires additional investigations.

Learn more about the unique Point-of-Care equipment that can determine HS Troponin here.

Troponin HS cardiac marker brochure

The Interdisciplinary Congress of Emergency Medicine organized by the Cluj Medical School aims to highlight the connections between various sets of medical data.

The presentations and the moderation of the discussions have been done by: Lecturer Dr. Adela Golea.

The symposium organized by Synttergy Consult has covered the following topics:

• Urgent action for the administration of antimicrobial therapy in the emergency department - Prof. Dr. Diana Cimpoesu, Chief Medical Doctor UPU-SMURD Iasi – Emergency Clinical Hospital “Sf. Spiridon” Iasi
• From the Point of Injury to the Hospital in one Breath - Yotam Biberman, Inovytech
• Digital Health and Technology - Reinforcing Community Health - Yotam Biberman, Inovytech
• Risks and errors in the interpretation of values biomarkers, in emergency practice - Conf. Dr. Adela Golea, Medical Director - Cluj-Napoca County Clinical Emergency Hospital
• The role of biomarkers in the diagnosis and treatment of heart failure and pulmonary embolism - Prof. Dr. Diana Tint
• Multimarker approach to acute coronary syndromes - differential diagnosis - Conf. Dr. Katalin Babes
• Invasive monitoring of the patient with cardiogenic shock in acute myocardial infarction. Therapeutic importance? - Prof. Dr. Adrian Iancu
• Biomarkers - from principles to clinical reality. Case presentation - Prof. Dr. Dumitru Zdrenghea